8 results on '"Gbadegesin, Rasheed A"'
Search Results
2. Hiding in plain sight: genetics of childhood steroid-resistant nephrotic syndrome in Sub-Saharan Africa.
- Author
-
Williams, Anna Elizabeth, Esezobor, Christopher I., Lane, Brandon M., and Gbadegesin, Rasheed A.
- Subjects
STEROID drugs ,DISEASE progression ,CHRONIC kidney failure ,GENETICS ,GENETIC mutation ,NEPHROTIC syndrome ,DRUG resistance ,RISK assessment ,GENOTYPES ,NEPHROTIC syndrome in children ,DISEASE risk factors - Abstract
Steroid-resistant nephrotic syndrome (SRNS) is the most severe form of childhood nephrotic syndrome with an increased risk of progression to chronic kidney disease stage 5. Research endeavors to date have identified more than 80 genes that are associated with SRNS. Most of these genes regulate the structure and function of the podocyte, the visceral epithelial cells of the glomerulus. Although individuals of African ancestry have the highest prevalence of SRNS, especially those from Sub-Saharan Africa (SSA), with rates as high as 30–40% of all cases of nephrotic syndrome, studies focusing on the characterization and understanding of the genetic basis of SRNS in the region are negligible compared with Europe and North America. Therefore, it remains unclear if some of the variants in SRNS genes that are deemed pathogenic for SRNS are truly disease causing, and if the leading causes of monogenic nephrotic syndrome in other populations are the same for children in SSA with SRNS. Other implications of this lack of genetic data for SRNS in the region include the exclusion of children from the region from clinical trials aimed at identifying potential novel therapeutic agents for this severe form of nephrotic syndrome. This review underlines a need for concerted efforts to advance the genetic basis of SRNS in children in SSA. Such endeavors will complement global efforts at understanding the genetic basis of nephrotic syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Rare variants in tenascin genes in a cohort of children with primary vesicoureteric reflux.
- Author
-
Elahi, Shan, Homstad, Alison, Vaidya, Himani, Stout, Jennifer, Hall, Gentzon, Wu, Guanghong, Conlon, Peter, Routh, Jonathan, Wiener, John, Ross, Sherry, Nagaraj, Shashi, Wigfall, Delbert, Foreman, John, Adeyemo, Adebowale, Gupta, Indra, Brophy, Patrick, Rabinovich, C., and Gbadegesin, Rasheed
- Subjects
DNA analysis ,VESICO-ureteral reflux ,CHI-squared test ,FISHER exact test ,GENES ,JOINT hypermobility ,GENETIC mutation ,RESEARCH funding ,PHENOTYPES ,GENETIC testing ,FAMILY history (Medicine) ,DATA analysis software ,DESCRIPTIVE statistics ,SEQUENCE analysis ,GENETICS ,DIAGNOSIS - Abstract
Background: Primary vesicoureteral reflux (PVUR) is the most common malformation of the kidney and urinary tract, and reflux nephropathy is a major cause of chronic kidney disease in children. Recently, we reported mutations in the tenascin XB gene ( TNXB) as a cause of PVUR with joint hypermobility. Methods: To define the role of rare variants in tenascin genes in the etiology of PVUR, we screened a cohort of patients with familial PVUR (FPVUR) and non-familial PVUR (NFPVUR) for rare missense variants in TNXB and the tenascin C gene ( TNC) after excluding mutations in ROBO2 and SOX17. Results: The screening procedure identified 134 individuals from 112 families with PVUR; two families with mutations in ROBO2 were excluded from further analysis. Rare missense variants in TNXB were found in the remaining 110 families, of which 5/55 (9 %) families had FPVUR and 2/55 (4 %) had NFPVUR. There were no differences in high-grade reflux or renal parenchymal scarring between patients with and without TNXB variants. All patients with TNXB rare variants who were tested exhibited joint hypermobility. Overall we were able to identify causes of FPVUR in 7/57 (12 %) families (9 % in TNXB and 3 % in ROBO2). Conclusions: In conclusion, the identification of a rare missense variant in TNXB in combination with a positive family history of VUR and joint hypermobility may represent a non-invasive method to diagnose PVUR and warrants further evaluation in other cohorts. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
4. Variability in phenotype induced by the podocin variant R229Q plus a single pathogenic mutation.
- Author
-
Phelan, Paul J., Hall, Gentzon, Wigfall, Delbert, Foreman, John, Nagaraj, Shashi, Malone, Andrew F., Winn, Michelle P., Howell, David N., and Gbadegesin, Rasheed
- Subjects
NEPHROTIC syndrome ,GENETIC mutation ,IMMUNOSUPPRESSIVE agents ,GENETICS - Abstract
Background: Mutations in podocin (NPHS2) are the most common cause of childhood onset autosomal recessive steroid-resistant nephrotic syndrome (SRNS). The disease is characterized by early-onset proteinuria, resistance to immunosuppressive therapy and rapid progression to end-stage renal disease. Compound heterozygous changes involving the podocin variant R229Q combined with another pathogenic mutation have been associated with a mild phenotype with disease onset often in adulthood. Methods: We screened 19 families with early-onset SRNS for mutations in NPHS2 and WT1 and identified four disease-causing mutations (three in NPHS2 and one in WT1) prior to planned whole-exome sequencing. Results: We describe two families with three individuals presenting in childhood who are compound heterozygous for R229Q and one other pathogenic NPHS2 mutation, either L327F or A297V. One child presented at age 4 years (A297V plus R229Q) and the other two at age 13 (L327F plus R229Q), one with steadily deteriorating renal function. Conclusions: These cases highlight the phenotypic variability associated with the NPHS2 R229Q variant plus pathogenic mutation. Individuals may present with early aggressive disease. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
5. Exclusion of homozygous PLCE1 ( NPHS3) mutations in 69 families with idiopathic and hereditary FSGS.
- Author
-
Gbadegesin, Rasheed, Bartkowiak, Bartlomiej, Lavin, Peter, Mukerji, Nirvan, Wu, Guanghong, Bowling, Brandy, Eckel, Jason, Damodaran, Tirupapuliyur, and Winn, Michelle
- Subjects
- *
ETIOLOGY of diseases , *CHRONIC kidney failure , *NEPHROTIC syndrome , *GENETICS , *GENETIC mutation , *PEDIATRIC nephrology - Abstract
Focal and segmental glomerulosclerosis (FSGS) is the most common glomerular cause of end-stage kidney disease (ESKD). Although the etiology of FSGS has not been fully elucidated, recent results from the positional cloning of genes mutated in nephrotic syndromes are now beginning to provide insight into the pathogenesis of these diseases. Mutations in PLCE1/NPHS3 have recently been reported as a cause of nephrotic syndrome characterized by diffuse mesangial sclerosis (DMS) histology. One single family with a missense mutation had late onset of the disease that was characterized by FSGS. To further define the role of PLCE1 mutations in the etiology of FSGS, we performed mutational analysis in 69 families with FSGS. A total of 69 families with 231 affected individuals were examined. The median age of disease onset was 26 years (range 1–66 years). Onset of ESKD was at a median age of 35.5 years. Seven variants leading to non-synonymous changes were found, of which only two are new variants (exon 4 c.1682 G>A R561Q, exon 31 c.6518A>G K2173R). No known disease-causing mutations were identified in the families screened. PLCE1/NPHS3 mutations are not a cause of FSGS in this cohort. The absence of mutations in PLCE1/NPHS3 in this study indicates that there are additional genetic causes of FSGS and that hereditary FSGS is a heterogeneous disease. Kindreds appropriate for genome-wide screening are currently being subjected to analysis with the aim of identifying other genetic causes of FSGS. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
6. Thirteen novel NPHS1 mutations in a large cohort of children with congenital nephrotic syndrome.
- Author
-
Heeringa, Saskia F., Vlangos, Christopher N., Chernin, Gil, Hinkes, Bernward, Gbadegesin, Rasheed, Liu, Jinhong, Hoskins, Bethan E., Ozaltin, Fatih, and Hildebrandt, Friedhelm
- Subjects
GENETIC mutation ,NEPHROTIC syndrome in children ,KIDNEY diseases ,GENETIC disorders ,SYNDROMES - Abstract
Background. Congenital nephrotic syndrome (CNS) is de- fined as nephrotic syndrome that manifests at birth or within the first 3 months of life. Most patients develop end-stage renal disease (ESRD) within 2 to 3 years of life. CNS of the Finnish-type (CNF) features a rather specific renal histology and is caused by recessive mutations in the NPHS1 gene encoding nephrin, a major structural protein of the glomerular slit-diaphragm. So far, more than 80 different mutations of NPHS1 causing CNF have been published. [ABSTRACT FROM PUBLISHER]
- Published
- 2008
- Full Text
- View/download PDF
7. Low prevalence of NPHS2 mutations in African American children with steroid-resistant nephrotic syndrome.
- Author
-
Chernin, Gil, Heeringa, Saskia F., Gbadegesin, Rasheed, Liu, Jinhong, Hinkes, Bernward G., Vlangos, Christopher N., Vega-Warner, Virginia, and Hildebrandt, Friedhelm
- Subjects
AFRICAN American children ,GENETIC disorders ,KIDNEY diseases ,NEPHROTIC syndrome ,GENETIC mutation ,DISEASES - Abstract
In African American (AA) children, focal segmental glomerulosclerosis (FSGS) is the leading cause of nephrotic syndrome (NS). It has been shown that AA children suffer from FSGS and steroid-resistant nephrotic syndrome (SRNS) at a higher frequency and with a more severe renal outcome in comparison with Caucasian children. Previous mutation analysis of large cohorts revealed that a high percentage of childhood SRNS is monogenic and that mutations in podocin ( NPHS2) and Wilms’ tumor gene 1 ( WT1) account for approximately 30% of SRNS in children. To test whether AA children with SRNS have a similar or a higher mutation rate, we performed mutation analysis of NPHS2 and WT1 in a cohort of AA children with SRNS. Direct sequencing was carried out for all exons of NPHS2 and for exons 8 and 9 of WT1. We ascertained 18 children of AA descent in whom renal biopsy findings showed FSGS in 13 patients (72%) and minimal-change disease in five patients (28%). In both NPHS2 and WT1, no disease-causing mutations were detected. Our data strongly suggest that in AA children with SRNS, the frequency of NPHS2 mutations is much lower than in large cohorts of pediatric SRNS patients in the general population. Knowledge of mutation rate of NPHS2 in different populations of SRNS patients facilitates the physician in planning a suitable genetic screening strategy for patients. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
8. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible.
- Author
-
Hinkes, Bernward, Wiggins, Roger C., Gbadegesin, Rasheed, Vlangos, Christopher N., Seelow, Dominik, Nürnberg, Gudrun, Garg, Puneet, Verma, Rakesh, Chaib, Hassan, Hoskins, Bethan E., Ashraf, Shazia, Becker, Christian, Hennies, Hans Christian, Goyal, Meera, Wharram, Bryan L., Schachter, Asher D., Mudumana, Sudha, Drummond, Iain, Kerjaschki, Dontscho, and Waldherr, Rüdiger
- Subjects
NEPHROTIC syndrome ,CLONING ,GENETIC mutation ,PROTEINURIA ,EDEMA ,KIDNEY diseases ,PHOSPHOLIPASE C ,IMMUNOFLUORESCENCE - Abstract
Nephrotic syndrome, a malfunction of the kidney glomerular filter, leads to proteinuria, edema and, in steroid-resistant nephrotic syndrome, end-stage kidney disease. Using positional cloning, we identified mutations in the phospholipase C epsilon gene (PLCE1) as causing early-onset nephrotic syndrome with end-stage kidney disease. Kidney histology of affected individuals showed diffuse mesangial sclerosis (DMS). Using immunofluorescence, we found PLCε1 expression in developing and mature glomerular podocytes and showed that DMS represents an arrest of normal glomerular development. We identified IQ motif–containing GTPase-activating protein 1 as a new interaction partner of PLCε1. Two siblings with a missense mutation in an exon encoding the PLCε1 catalytic domain showed histology characteristic of focal segmental glomerulosclerosis. Notably, two other affected individuals responded to therapy, making this the first report of a molecular cause of nephrotic syndrome that may resolve after therapy. These findings, together with the zebrafish model of human nephrotic syndrome generated by plce1 knockdown, open new inroads into pathophysiology and treatment mechanisms of nephrotic syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.